Dihydrogenated Alkaloids of Ergotoxine in Non-Hospitalised Elderly Patients
- 1 January 1975
- journal article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 3 (7) , 464-468
- https://doi.org/10.1185/03007997509113688
Abstract
A controlled trial of dihydrogenated alkaloids of ergotoxine in 32 elderly patients with arteriosclerotic and in 46 with non-arteriosclerotic dementias was conducted whilst the patients were still in the community. There was a significant improvement in the patients receiving this drug as judged by the improvement of the clinical picture and the length of time before hospitalisation became necessary. The initial improvement was, however, not sustained for the whole duration of the trial.Keywords
This publication has 7 references indexed in Scilit:
- PSYCHOGERIATRICS AND COMMUNITY CAREThe Lancet, 1975
- A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.Current Medical Research and Opinion, 1974
- An Ergot Alkaloid Preparation (Hydergine) versus Papaverine in Treating Common Complaints of the Aged: Double‐Blind StudyJournal of the American Geriatrics Society, 1973
- An Ergot Alkaloid Preparation (Hydergine) Versus Placebo for Treatment of Symptoms of Cerebrovascular Insufficiency: Double‐Blind StudyJournal of the American Geriatrics Society, 1972
- AN ERGOT PREPARATION (HYDERGINE) IN THE TREATMENT OF CEREBROVASCULAR DISORDERS IN THE GERIATRIC PATIENT: DOUBLE‐BLIND STUDYJournal of the American Geriatrics Society, 1971
- Old Age Mental Disorders in Newcastle upon TyneThe British Journal of Psychiatry, 1964
- Some Problems of Clinical Trials in Elderly PeopleGerontologia Clinica, 1961